287 related articles for article (PubMed ID: 17599423)
1. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Gerstein HC; Riddle MC; Kendall DM; Cohen RM; Goland R; Feinglos MN; Kirk JK; Hamilton BP; Ismail-Beigi F; Feeney P;
Am J Cardiol; 2007 Jun; 99(12A):34i-43i. PubMed ID: 17599423
[TBL] [Abstract][Full Text] [Related]
2. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
; Buse JB; Bigger JT; Byington RP; Cooper LS; Cushman WC; Friedewald WT; Genuth S; Gerstein HC; Ginsberg HN; Goff DC; Grimm RH; Margolis KL; Probstfield JL; Simons-Morton DG; Sullivan MD
Am J Cardiol; 2007 Jun; 99(12A):21i-33i. PubMed ID: 17599422
[TBL] [Abstract][Full Text] [Related]
3. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Bonds DE; Kurashige EM; Bergenstal R; Brillon D; Domanski M; Felicetta JV; Fonseca VA; Hall K; Hramiak I; Miller ME; Osei K; Simons-Morton DG;
Am J Cardiol; 2007 Jun; 99(12A):80i-89i. PubMed ID: 17599428
[TBL] [Abstract][Full Text] [Related]
4. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
5. Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).
Chew EY; Ambrosius WT; Howard LT; Greven CM; Johnson S; Danis RP; Davis MD; Genuth S; Domanski M;
Am J Cardiol; 2007 Jun; 99(12A):103i-111i. PubMed ID: 17599420
[TBL] [Abstract][Full Text] [Related]
6. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
7. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial.
Hempe JM; Liu S; Myers L; McCarter RJ; Buse JB; Fonseca V
Diabetes Care; 2015 Jun; 38(6):1067-74. PubMed ID: 25887355
[TBL] [Abstract][Full Text] [Related]
8. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
9. Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD.
Hoogwerf BJ; ;
Cleve Clin J Med; 2008 Oct; 75(10):729-37. PubMed ID: 18939389
[TBL] [Abstract][Full Text] [Related]
10. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Goff DC; Gerstein HC; Ginsberg HN; Cushman WC; Margolis KL; Byington RP; Buse JB; Genuth S; Probstfield JL; Simons-Morton DG;
Am J Cardiol; 2007 Jun; 99(12A):4i-20i. PubMed ID: 17599424
[TBL] [Abstract][Full Text] [Related]
12. Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial.
Miller ME; Williamson JD; Gerstein HC; Byington RP; Cushman WC; Ginsberg HN; Ambrosius WT; Lovato L; Applegate WB;
Diabetes Care; 2014; 37(3):634-43. PubMed ID: 24170759
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
Meier M; Hummel M
Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.
Margolis KL; O'Connor PJ; Morgan TM; Buse JB; Cohen RM; Cushman WC; Cutler JA; Evans GW; Gerstein HC; Grimm RH; Lipkin EW; Narayan KM; Riddle MC; Sood A; Goff DC
Diabetes Care; 2014 Jun; 37(6):1721-8. PubMed ID: 24595629
[TBL] [Abstract][Full Text] [Related]
15. Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial.
Schwartz AV; Margolis KL; Sellmeyer DE; Vittinghoff E; Ambrosius WT; Bonds DE; Josse RG; Schnall AM; Simmons DL; Hue TF; Palermo L; Hamilton BP; Green JB; Atkinson HH; O'Connor PJ; Force RW; Bauer DC
Diabetes Care; 2012 Jul; 35(7):1525-31. PubMed ID: 22723583
[TBL] [Abstract][Full Text] [Related]
16. Importance of glucose control.
Edelman SV
Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
[TBL] [Abstract][Full Text] [Related]
17. [Glycemic control and cardiovascular benefit: What do we know today?].
Hanefeld M; Schönauer M; Forst T
Dtsch Med Wochenschr; 2010 Feb; 135(7):301-7. PubMed ID: 20146161
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC; Cull CA; Frighi V; Holman RR
JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions.
Roussel R; Steg PG; Mohammedi K; Marre M; Potier L
Diabetes Obes Metab; 2018 Feb; 20(2):238-244. PubMed ID: 28597588
[TBL] [Abstract][Full Text] [Related]
20. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
Bonds DE; Miller ME; Bergenstal RM; Buse JB; Byington RP; Cutler JA; Dudl RJ; Ismail-Beigi F; Kimel AR; Hoogwerf B; Horowitz KR; Savage PJ; Seaquist ER; Simmons DL; Sivitz WI; Speril-Hillen JM; Sweeney ME
BMJ; 2010 Jan; 340():b4909. PubMed ID: 20061358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
